Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Aethlon Medical Signs $150M M&A Deal with North Immunology, Inc.
Aethlon Medical (AEMD) has entered into a definitive agreement to acquire North Immunology in an all-stock merger transaction valued at a framework of $150 million for the target. Concurrent with the merger, North Immunology secured an oversubscribed $180 million private placement from a syndicate of healthcare investors to fund operations into 2028. The combined company will focus on advancing NOR-101, a bispecific antibody for atopic dermatitis, and will trade under the new ticker NRTX.
HeartSciences M&A Deal with Fortitude Mining Holdings, Inc.
HeartSciences provided a status update on its pending merger with Fortitude Mining Holdings, Inc., announcing that Jaime Leverton has been appointed CEO of Fortitude and is expected to lead the combined company (to be renamed Fortitude Mining Group, Inc.) upon closing. The update follows the definitive merger agreement signed on June 23, 2026, as the vertically-integrated Zcash mining platform prepares for its public listing on Nasdaq under the ticker 'TUDE'.
Atlanticus Holdings Corporation completed the sale of its CAR Auto Finance operations to an unaffiliated third party for approximately $71.2 million. The consideration consists of $56.2 million in cash and a $15.0 million seller note, and the transaction results in the company exiting its Auto Finance segment to focus on higher-growth consumer credit products.
Bank7 Signs $108M M&A Deal with Century Financial Services Corporation
Bank7 Corp. entered into a definitive agreement to acquire Century Financial Services Corporation, the parent company of Santa Fe-based Century Bank, for approximately $108.1 million in combined cash and stock. The deal expands Bank7's footprint into the New Mexico market and will create a combined institution with approximately $3.3 billion in total assets. Century shareholders will receive $70 million in cash and 1,232,657 shares of Bank7 common stock.
Value
$108M
Counterparty
Century Financial Services Corporation
“This transaction extends our footprint into an attractive and neighboring Southwest market, represents a disciplined use of our excess capital, and positions the combined organization to deliver personalized, high-touch service to even more business owners and entrepreneurs — all to the benefit of our customers, communities, and shareholders.”
Thomas L. Travis, President and CEO of Bank7
“We believe this is a great opportunity for both banks to enhance their presence in the southwest and create a stronger more robust banking institution to benefit our customers, employees, and communities.”
CXJ Group Co., Limited entered into a subscription agreement with Suwen Wang for the private placement of 124,000 shares of common stock. The transaction raised approximately $72,912 in net proceeds, which the company intends to use for general working capital.
Cenntro Inc. closed a private placement of 15,120,000 shares of common stock at a price of $3.773 per share, raising approximately $57.05 million in gross proceeds. The company amended an earlier agreement to increase the offering size and intends to use the funds for working capital and general corporate purposes.
BCB Bancorp, Inc. priced an underwritten public offering of 11,000,000 shares of common stock at $7.75 per share, generating gross proceeds of $85.25 million. The company intends to use the net proceeds for general corporate purposes, including maintaining liquidity, supporting bank capital, and reducing debt. Piper Sandler & Co. is acting as the sole book-running manager for the offering.
Mechanics Bancorp Divestiture to Bank of America for $417M
Mechanics Bancorp's subsidiary, Mechanics Bank, completed the sale of approximately $417 million in performing indirect auto loans to Bank of America's trading desk. The transaction involves the substantial majority of the company's runoff auto loan portfolio and was priced near book value. The divestiture is intended to optimize the balance sheet, reduce risk, and improve liquidity.
Beta Bionics, Inc. priced a public offering of 7,652,175 shares of common stock and pre-funded warrants for gross proceeds of approximately $150.0 million. The offering was priced at $17.25 per share, and the company granted underwriters a 30-day option to purchase up to an additional 1,304,348 shares. Proceeds are intended for general corporate purposes, including the commercialization of its Mint product and manufacturing facility expansion.
Value
$150M
Counterparty
J.P. Morgan Securities LLC, Piper Sandler & Co., Wells Fargo Securities, LLC and Leerink Partners LLC
Brand Engagement Network M&A Deal with Cataneo GmbH
Brand Engagement Network Inc. filed audited consolidated financial statements for Cataneo GmbH for the years ended December 31, 2025 and 2024. This filing provides required historical financial data following a previously announced acquisition or merger update involving Cataneo GmbH. The exhibit includes a full set of GAAP financial statements including balance sheets, operations, and cash flows.
Impact Biomedical Inc. announced the filing of a Form F-4 registration statement by Zoar Limited in connection with their previously announced business combination. The filing represents a major milestone toward closing the merger, which will result in a combined pharmaceutical company focused on active pharmaceutical ingredients and special therapeutic treatments. The transaction remains subject to SEC effectiveness, stockholder approval, and NYSE American listing approval.
Aperture AC Signs $150M M&A Deal with Atlantic HPC Group Inc
Aperture AC (SPAC) has entered into a definitive business combination agreement to acquire Atlantic HPC Group Inc for an aggregate merger consideration of $150 million. Upon closing, Atlantic HPC Group will become a wholly owned subsidiary of the re-domiciled Delaware corporation, and its stockholders may receive up to 6 million additional earnout shares based on future performance milestones.
Tenon Medical entered into an inducement agreement with an institutional investor to exercise existing warrants for 572,179 shares of common stock at $5.02 per share. In exchange for the cash exercise, the company issued new unregistered five-year warrants to purchase up to 858,269 shares at the same exercise price. The transaction generated approximately $2.87 million in gross proceeds for working capital and general corporate purposes.
Battalion Oil Corporation has regained compliance with NYSE American's continued listing standards regarding minimum stockholders' equity. The company resolved the deficiency ahead of its November 30, 2026 deadline after demonstrating compliance for two consecutive quarters. Consequently, the exchange will remove the company from its list of noncompliant issuers and cease disseminating the associated compliance indicator.
Clene Inc. entered into a securities purchase agreement for a $4.0 million registered direct offering of 1,219,513 shares of common stock at $3.28 per share. The offering was led by the company's Chairman and CEO alongside existing investors to fund regulatory filings for its lead drug candidate, CNM-Au8, and general corporate purposes. The proceeds are expected to extend the company's cash runway through mid-first quarter 2027.
Value
$4M
Counterparty
David Matlin, Kensington Capital Holdings, and other existing stockholders
DataMeds AI Signs $1.5M M&A Deal with Helomics Corporation
DataMeds AI acquired Helomics Corporation, an AI cancer diagnostics lab and precision oncology CRO, from Axe Compute Inc. for $1.5 million in total consideration consisting of 636,328 common shares and a $1.36 million convertible promissory note. The acquisition expands DataMeds' services into the oncology market and includes a CLIA/CAP-certified clinical laboratory and $1.5 million in cash.
Wolfspeed, Inc. filed unaudited pro forma consolidated financial information reflecting the impact of its prepackaged plan of reorganization which became effective on September 29, 2025. The filing details the adoption of fresh start accounting and the financial effects of receiving regulatory approvals related to the restructuring plan, including the issuance of shares to Renesas.
Adial Pharmaceuticals M&A Deal with Azora Therapeutics, Inc.
Adial Pharmaceuticals provided a status update on its previously announced acquisition of Azora Therapeutics, including the entry into amendments to the Securities Purchase Agreement and Note Exchange Agreements. The amendments remove a 'Penalty Provision' related to Milestone Warrants and add lock-up restrictions, resulting in a reclassification of certain warrant rights from liability to equity on the company's balance sheet.
Bone Biologics Corp received a deficiency notice from Nasdaq on September 10, 2026, because its common stock failed to maintain a minimum bid price of $1.00 for 30 consecutive business days. The company has 180 calendar days, until March 9, 2027, to regain compliance and intends to seek shareholder approval for a reverse stock split to address the deficiency.
Golub Capital BDC 4, Inc. issued a capital drawdown notice to its stockholders for the sale of approximately 4.54 million shares of common stock. The transaction is expected to raise $68.07 million in gross proceeds and is scheduled to close on or around September 24, 2026.
BCB Bancorp has launched an underwritten public offering of its common stock to raise capital for general corporate purposes and to support the bank's capital ratios. Simultaneously, the company announced a major balance sheet cleanup involving the marketing for sale of approximately $210 million in problem loans and the divestiture of its cannabis-related business lines. Due to these asset sales and a $50 million tax valuation allowance, the company expects to report a significant net loss between $126.2 million and $136.1 million for the third quarter of 2026.
Synergy CHC Corp. received a delisting notice from Nasdaq on September 11, 2026, following the company's voluntary Chapter 11 bankruptcy filing. Trading of the company's common stock is expected to be suspended on September 18, 2026, as the company does not intend to appeal the determination.
Range Capital Acquisition Nasdaq/NYSE Compliance Notice
Range Capital Acquisition Corp. received a deficiency notice from Nasdaq on September 11, 2026, for failing to meet the minimum requirement of 400 total holders for continued listing on the Nasdaq Global Market. The company has 45 days to submit a compliance plan and may be granted up to 180 days to regain compliance if the plan is accepted.
Sysco Corporation closed a public offering of 12,345,679 shares of common stock at $81.00 per share, generating approximately $967.4 million in net proceeds. The company intends to use the funds to finance a portion of its pending acquisition of JRD Unico, Inc. and Warehouse Realty, LLC. The underwriters were also granted a 30-day option to purchase an additional 1,851,851 shares to cover overallotments.
Ares Industrial Real Estate Income Trust Capital Raise of $5.1B
Ares Industrial Real Estate Income Trust reported its monthly Net Asset Value (NAV) as of August 31, 2026, totaling approximately $5.1 billion across its share classes. The filing provides an update on its continuous public offering and DST Program, noting that transaction prices for October 1, 2026, will be based on the August 31 NAV per share.
Generac Holdings Wins $8B Contract from Amazon.com, Inc.
Generac entered into a long-term supply agreement with Amazon to provide backup power generators for Amazon data centers, with a total potential contract value of $8 billion. In connection with the deal, Generac issued Amazon a warrant to purchase up to 1.69 million shares at $200.93 per share, with vesting tied to the achievement of specific payment milestones.
BuzzFeed, Inc. entered into a share purchase agreement to issue 1,700,000 new shares of Class A common stock to Allen Family Digital, LLC, an affiliate of Chairman Byron Allen. The private placement raised approximately $1.8 million at a price of $1.06 per share, representing the closing price on the day prior to the agreement.
K&F Growth Acquisition Corp. II Nasdaq/NYSE Compliance Notice
K&F Growth Acquisition Corp. II successfully transferred its securities from the Nasdaq Global Market to the Nasdaq Capital Market effective September 16, 2026. This transfer resolved a previous deficiency notice regarding Nasdaq's minimum requirement of 400 total holders, rendering the compliance issue moot.
Generation Income Properties Nasdaq/NYSE Compliance Notice
Generation Income Properties received a determination from the Nasdaq Hearings Panel granting an extension until November 18, 2026, to regain compliance with the $1.00 minimum bid price requirement. The company had previously received a deficiency notice and requested a hearing to stay delisting proceedings while it works to address the stock price issue.
Vivani Medical provided a status update on the pending merger of its wholly owned subsidiary, Cortigent, Inc., with ClearOne, Inc. The company anticipates that the pricing and closing of the transaction will occur in October 2026. Following the merger, Cortigent will become a wholly owned subsidiary of ClearOne.